"The efficacy and safety of ipilimumab (MDX-010) in patients with unresectable stage III or stage IV malignant melanoma" by J. S. Weber

Selected Works of Walter J. Urba, MD, PhD

Follow Contact

Article

The efficacy and safety of ipilimumab (MDX-010) in patients with unresectable stage III or stage IV malignant melanoma

Journal of Clinical Oncology (2007)

J. S. Weber, University of Southern California
E. M. Hersh, University of Arizona
M. Yellin, Medarex
G. M. Nichol, Medarex
W. Urba, Providence Portland Medical Center
J. D. Powderly, Medarex
S. J. O'Day, University of Arizona

Disciplines

Medicine and Health Sciences and
Pathology

Publication Date

June 20, 2007

Citation Information

J. S. Weber, E. M. Hersh, M. Yellin, G. M. Nichol, et al.. "The efficacy and safety of ipilimumab (MDX-010) in patients with unresectable stage III or stage IV malignant melanoma" Journal of Clinical Oncology Vol. 25 (2007) p. 8523
Available at: http://works.bepress.com/walter-urba/179/